150 related articles for article (PubMed ID: 8611395)
1. Dipyridamole increases VP16 growth inhibition, accumulation and retention in parental and multidrug-resistant CHO cells.
Turner RN; Curtin NJ
Br J Cancer; 1996 Apr; 73(7):856-60. PubMed ID: 8611395
[TBL] [Abstract][Full Text] [Related]
2. Dipyridamole-mediated reversal of multidrug resistance in MRP over-expressing human lung carcinoma cells in vitro.
Curtin NJ; Turner DP
Eur J Cancer; 1999 Jun; 35(6):1020-6. PubMed ID: 10533488
[TBL] [Abstract][Full Text] [Related]
3. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.
Desai PB; Duan J; Sridhar R; Damle BD
Methods Find Exp Clin Pharmacol; 1997 May; 19(4):231-9. PubMed ID: 9228648
[TBL] [Abstract][Full Text] [Related]
4. Dipyridamole reverses the resistance to topoisomerase II inhibitors but not to antimicrotubule agents in multidrug-resistant melanoma cells.
Damle B; Desai P
Oncol Res; 1994; 6(2):49-57. PubMed ID: 7949465
[TBL] [Abstract][Full Text] [Related]
5. FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1.
Xing Y; Wang ZH; Ma DH; Han Y
J Dig Dis; 2014 May; 15(5):246-59. PubMed ID: 24868599
[TBL] [Abstract][Full Text] [Related]
6. A unique interaction between polyamine and multidrug resistance (P-glycoprotein) transporters in cultured Chinese hamster ovary cells transfected with mouse mdr-1 gene.
Aziz SM; Worthen DR; Yatin M; Ain KB; Crooks PA
Biochem Pharmacol; 1998 Jul; 56(2):181-7. PubMed ID: 9698071
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of cytotoxicity of mitoxantrone toward CHO-K1 cells in vitro by dipyridamole.
Desai PB; Sridhar R
Pharm Res; 1992 Feb; 9(2):178-81. PubMed ID: 1553337
[TBL] [Abstract][Full Text] [Related]
8. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
9. Is rhodamine 123 an appropriate fluorescent probe to assess P-glycoprotein mediated multidrug resistance in vinblastine-resistant CHO cells?
Pétriz J; O'Connor JE; Carmona M; García-López J
Anal Cell Pathol; 1997; 14(3):129-40. PubMed ID: 9354229
[TBL] [Abstract][Full Text] [Related]
10. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
11. Reversal of doxorubicin resistance by tetrandrine in Chinese hamster ovary cell line.
He QY; Jiang B; Zhang HQ; Xue SB
Zhongguo Yao Li Xue Bao; 1992 Sep; 13(5):416-9. PubMed ID: 1300043
[TBL] [Abstract][Full Text] [Related]
12. Melphalan resistance and photoaffinity labelling of P-glycoprotein in multidrug-resistant Chinese hamster ovary cells: reversal of resistance by cyclosporin A and hyperthermia.
Larrivée B; Averill DA
Biochem Pharmacol; 1999 Jul; 58(2):291-302. PubMed ID: 10423171
[TBL] [Abstract][Full Text] [Related]
13. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance to combinations of vincristine, etoposide and doxorubicin in Chinese hamster ovary cells.
Souès S; Laval F; Charcosset JY
Br J Cancer; 1995 Mar; 71(3):489-97. PubMed ID: 7880729
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
Watanabe Y; Takano H; Kiue A; Kohno K; Kuwano M
Anticancer Drug Des; 1991 Feb; 6(1):47-57. PubMed ID: 2015041
[TBL] [Abstract][Full Text] [Related]
16. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
Li H; Krstin S; Wink M
Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
[TBL] [Abstract][Full Text] [Related]
17. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin.
Zong L; Cheng G; Liu S; Pi Z; Liu Z; Song F
J Pharm Biomed Anal; 2019 Feb; 165():268-275. PubMed ID: 30572191
[TBL] [Abstract][Full Text] [Related]
18. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K
Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability.
Drori S; Eytan GD; Assaraf YG
Eur J Biochem; 1995 Mar; 228(3):1020-9. PubMed ID: 7737146
[TBL] [Abstract][Full Text] [Related]
20. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
